𝔖 Bobbio Scriptorium

✦ LIBER ✦

What is the optimal leading follicular size for triggering final oocyte maturation with gonadotropin-releasing hormone agonist?

✍ Scribed by Das, M.; Carby, A.; Abdo, D.; Marta, J.; Trew, G.; Lavery, S.

Book ID: 123505598
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 49 KB
Volume: 100
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2013.07.1098

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gonadotropin-releasing hormone agonist t

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

✍ Andrea J. DiLuigi; Lawrence Engmann; David W. Schmidt; Donald B. Maier; John C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Lower serum levels of inhibin A and pro-

Lower serum levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with gonadotropin releasing hormone (GnRH) agonist in comparison to human chorionic gonadotropin (hCG): possible relevance for the prevention of ovarian hyperstimulation (OHSS)

✍ Ori Nevo; Talia Eldar-Geva; Shahar Kol; Joseph Itskovitz-Eldor 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 22 KB

Prevention of Ovarian Hyperstimulation S

Prevention of Ovarian Hyperstimulation Syndrome (OHSS) With the Use of Gonadotropin Releasing Hormone (GnRH) Agonist to Trigger Final Oocyte Maturation After Cotreatment With GnRH Antagonist in Patients With Polycystic Ovarian Syndrome (PCOS) or Previous High Response Undergoing IVF Treatment—A Prospective Randomized Clinical Trial

✍ L. Engmann; A. Diluigi; D. Schmidt; J. Nulsen; D. Maier; C. Benadiva 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB